INSIGHTS ON DRUG DEVELOPMENT
-
![Cell and gene tech exp bucket image]( "How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics")
How CRISPR And LNP Accelerate Therapeutic Innovation Through AnalyticsCRISPR gene editing and lipid nanoparticle delivery are revolutionizing precision medicine. Discover how optimized LNP systems and advanced analytics accelerate therapeutic development.
-
![Lonza_AI Drug_OPCU_Feb_2026]( "Lonza Advanced Synthesis Capabilities Update September 2026: AI Drug Manufacturing")
Lonza Advanced Synthesis Capabilities Update September 2026: AI Drug ManufacturingLearn how our scientists accurately predict and identify the most stable cocrystal forms by leveraging advanced machine learning models, enhancing efficiency and reducing development risks.
-
![GettyImages-1253545551-OSD-pill-tablet-oral-solid-dose]( "How L-Leucine Shapes Spray-Dried Particles")
How L-Leucine Shapes Spray-Dried ParticlesOptimizing L-Leucine balances porosity and surface enrichment in spray-dried formulations. Precise adjustments alter particle structure to enhance aerodynamic performance and lung deposition.
-
![GettyImages-1751659695-laboratory-scientists-computer-analysis-evaluation]( "Doubling Up For Speed In Biomanufacturing")
Doubling Up For Speed In BiomanufacturingAccelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.
-
Where Speed Meets Complexity In Bioprocess Development6/18/2026
Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.
-
Rethinking Design, Cost, And Scalability In Biomanufacturing3/24/2026
Life science teams increasingly need tools that scale, simplify workflows, and reduce operational costs. Examine how emerging instrumentation focuses on usability, performance, and manufacturability.
-
From Lipids To Launch: End-To-End Therapy Development8/20/2026
Explore integrated capabilities spanning lipid manufacturing, nanoparticle formulation, and more with support designed to move complex therapies from preclinical development through commercialization.
-
How Peptides Became Cornerstones Of Modern Medicine5/18/2026
Peptides evolved from early chemical discoveries to transformative therapies, culminating in GLP‑1 drugs that highlight their versatility, precision, and expanding role across modern medicine.
-
Get More From Less: AMP Chemistry Outperforms Hybrid Capture6/9/2026
Sequencing performance can drop quickly with low-quality, low-input FFPE DNA. Gain insight into how one approach helps labs minimize repeats and maintain more consistent results.
DRUG DEVELOPMENT SOLUTIONS
-
![HSC-Kit-Box-and-Vials_100ul_0324]( "CD34+ HSC LNP Kits")
Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.
-
![ÄKTA oligosynt™ oligonucleotide synthesizer]( "Meet The Latest Member Of The Oligo Synthesis Family")
Discover a system with a flexible synthesis scale, intuitive software, and robust process control that is ideal for labs moving from research to production.
-
![GettyImages-1306664598 lab research]( "Bionanoparticle Technology")
Nanoform’s proprietary bionanoparticle technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. This can not only enable more patient-friendly approaches to drug delivery, but also potentially higher loads of active ingredients.
-
![Scientists working laboratory-GettyImages-1441663123]( "Tailored Process Development Services Designed For Success")
Explore the design services offered by the Gibco Media by Design team including cell line development, media and feed panel evaluations, bioproduction analytics and more.
-
![ExionLC™ 2.0 and ExionLC™]( "ExionLC™ 2.0 and ExionLC™ 2.0+ Systems")
Reproducibility, reliability and carryover performance that meets your workflow demands, injection to injection, batch after batch.
ExionLC 2.0 and ExionLC 2.0+ systems provide full integration, control and compatibility with SCIEX mass spectrometers bringing together the speed and precision you expect for a complete solution that meets every challenge your lab faces.
